Relationship of homocysteine with other risk factors and outcome of ischemic stroke

被引:75
作者
Kalita, Jayantee [1 ]
Kumar, Gyanendra [1 ]
Bansal, Vikas [1 ]
Misra, Usha Kant [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Lucknow 226014, Uttar Pradesh, India
关键词
Homocysteine; Ischemic stroke; Risk factors; Outcome; CT; MRI; PLASMA HOMOCYSTEINE; MYOCARDIAL-INFARCTION; HYPERHOMOCYSTEINEMIA; PREVALENCE; DEFICIENCY; POLYMORPHISM; VITAMIN-B12; POPULATION; DISEASE; ACID;
D O I
10.1016/j.clineuro.2008.12.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Hyperhomocysteinemia (HH) is an emerging risk factor for ischemic stroke but its role in outcome is controversial. We compare the risk factors, nature of stroke and outcome of patients with and without hyperhomocysteinemia. Patients and methods: CT proven ischemicstroke patients were included. The conventional risk factors such as diabetes, hypertension, hyperlipidemia, obesity, smoking, and family history of stroke were recorded. Dietary history was noted. Fasting serum homocysteine (Hcy). B12 and folic acid were estimated after 1 Dietary month of stroke. Severity of stroke was assessed by Canadian Neurological Scale (CNS) and outcome at 3 months by Barthel Index (BI) score into good (B1 >= 12) and poor (BI <= 12). Serum Hcy, B12 and folic acid were also estimated in 200 normal healthy volunteers. Results: There were 198 patients with ischemic stroke whose median age was 56 years and 36 were females. In the study group, 41.4% patients were vegetarian, 55.1% hypertensive, 24.7% diabetic, 30.8% smoker, 61.1% sedentary and 28.8% obese. 23.2% had past history of stroke and 21.7% had stroke in their first degree relative. Serum cholesterol was elevated in 11.7% and LDL in 10.8% patients. Serum Hcy was elevated in 60.6% and serum B12 low in 25.7% and folic acid in 42.1%. Hcy levels correlated with serum B12 and LDL. Patients with hyperhomocysteinemia had significantly better outcome at 3 months. Hcy levels in stroke patients did not significantly differ from controls. Conclusion: Hyperhomocysteinemia is found in 60.6% stroke patients, which is related to low serum B12 level. Patients with hyperhomocysteinemia had a better 3-month outcome. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 33 条
  • [1] MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study
    Alluri, RV
    Mohan, V
    Komandur, S
    Chawda, K
    Chaudhuri, JR
    Hasan, Q
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (01) : 40 - 44
  • [2] Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
    Anand, SS
    Yusuf, S
    Vuksan, V
    Devanesen, S
    Teo, KK
    Montague, PA
    Kelemen, L
    Yi, CL
    Lonn, E
    Gerstein, H
    Hegele, RA
    McQueen, M
    [J]. LANCET, 2000, 356 (9226) : 279 - 284
  • [3] Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
    Bostom, AG
    Lathrop, L
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (01) : 10 - 20
  • [4] HYPERHOMOCYSTEINAEMIA IN STROKE - PREVALENCE, CAUSE, AND RELATIONSHIPS TO TYPE OF STROKE AND STROKE RISK-FACTORS
    BRATTSTROM, L
    LINDGREN, A
    ISRAELSSON, B
    MALINOW, MR
    NORRVING, B
    UPSON, B
    HAMFELT, A
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (03) : 214 - 221
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] THE CANADIAN NEUROLOGICAL SCALE - A PRELIMINARY-STUDY IN ACUTE STROKE
    COTE, R
    HACHINSKI, VC
    SHURVELL, BL
    NORRIS, JW
    WOLFSON, C
    [J]. STROKE, 1986, 17 (04) : 731 - 737
  • [7] Dharmarajan TS, 2003, GERIATRICS, V58, P30
  • [8] An alternative view of homocysteine
    Dudman, NPB
    [J]. LANCET, 1999, 354 (9195) : 2072 - 2074
  • [9] Homocysteine and vascular disease
    Hankey, GJ
    Eikelboom, JW
    [J]. LANCET, 1999, 354 (9176) : 407 - 413
  • [10] Homocysteine and stroke
    Hankey, GJ
    Eikelboom, JW
    [J]. CURRENT OPINION IN NEUROLOGY, 2001, 14 (01) : 95 - 102